- Home
- VZLA vs AORT Comparison
VZLA vs AORT Comparison
Compare VZLA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VZLA | AORT |
|---|---|---|
| Founded | 2017 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VZLA | AORT |
|---|---|---|
| Price | $3.29 | $20.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $40.91 |
| AVG Volume (30 Days) | ★ 3.5M | 507.9K |
| Earning Date | 09-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $11.17 |
| Revenue Next Year | N/A | $10.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $2.88 | $19.16 |
| 52 Week High | $7.19 | $48.25 |
Technical Indicators
Market Signals| Indicator | VZLA | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 38.18 |
| Support Level | $3.06 | $19.73 |
| Resistance Level | $3.55 | $24.41 |
| Average True Range (ATR) | 0.18 | 1.29 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 73.96 | 4.37 |
Price Performance
Historical ComparisonAbout VZLA Vizsla Silver Corp.
Vizsla Silver Corp is the exploration of mineral properties. The company currently conducts substantially all its operations in Canada and Mexico in one reportable segment. The company has one reportable segment, mainly mineral exploration, evaluation and development. Its project includes Panuco Project.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.